Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Mrs. Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Mrs. Claudia Pauciulo | Borghesiana Veterinary Clinic | Italy

Mrs. Claudia Pauciulo is the Head of the Neurology and Neurosurgery Department at Borghesiana Veterinary Clinic in Rome, Italy, and a certified veterinary neurologist completing her ECVN Residency. She holds a Master’s Degree in Diagnostic Imaging and a GP Certificate in Neurology, combining strong academic training with extensive clinical experience in advanced diagnostics (MRI, CT), neurosurgery, and case management. Her research focuses on feline and canine hyperesthesia syndromes, central nervous system lymphoma, intervertebral disc disease, and peripheral neuropathies. Dr. Pauciulo has published as both first author and coauthor in high-impact, peer-reviewed journals, including the Journal of Veterinary Internal Medicine, Journal of the American Veterinary Medical Association, Veterinary Record Case Reports, Journal of Small Animal Practice, and Veterinary Sciences (MDPI). She maintains an active citation record with growing visibility in Scopus- and SCI-indexed publications. Her current h-index is 2, with a total of 10 citations across multiple publications. Through her collaborative research with leading ECVN diplomates and contributions to international neurology congresses, Dr. Pauciulo continues to advance veterinary neuroscience, integrating clinical excellence with innovative research to improve evidence-based therapeutic strategies for neurological disorders in companion animals.

Profiles: Orcid | Linked In

Featured Publication

Pauciulo, C., & Gallucci, A. (2025, September 25). Long‐term outcome of presumptive idiopathic hyperesthesia syndrome in a dog treated with fluoxetine. Veterinary Record Case Reports.

Watit Sontising | Neuroscience | Best Researcher Award

Dr. Watit Sontising | Neuroscience | Best Researcher Award

Dr. Watit Sontising | Icahn school of medicine at mount sinai | United States

Dr. Watit Sontising is a distinguished chemist whose career seamlessly integrates academic scholarship, industrial innovation, and biomedical research. With a foundation built through advanced studies in chemistry, his expertise spans computational modeling, analytical method development, and environmental compliance. His academic contributions include years of teaching and mentoring in general chemistry, fostering critical thinking and practical skills among diverse student groups. Professionally, he has advanced laboratory efficiency in environmental and industrial chemistry while later transitioning into biotechnology and biomedical research. His current postdoctoral work at the Icahn School of Medicine at Mount Sinai exemplifies his interdisciplinary impact, where he pioneers mass spectrometry imaging and metabolomic profiling to explore neurological disorders. Through a robust portfolio of publications and methodological innovations, he has significantly contributed to the fields of crystallography, material science, and spatial metabolomics.

Profile

Google Scholar

Early Academic Pursuits

Dr. Watit Sontising began his academic journey in chemistry with a strong foundation developed during his undergraduate studies in Thailand. His early exposure to chemical sciences sparked a curiosity for understanding molecular interactions and their implications in both natural and applied systems. Pursuing graduate studies in the United States, he advanced his expertise through master’s and doctoral programs in chemistry at the University of California, Riverside. During this time, he immersed himself in research on molecular interactions, computational chemistry, and crystallography, laying the groundwork for a career that bridges theory, experimentation, and application.

Professional Endeavors

His professional trajectory reflects a balance between academia and industry, allowing him to refine skills across diverse environments. At California State University, Fullerton, and later at the University of California, Riverside, he served as a teaching assistant in general chemistry, where he engaged directly with undergraduate students through lectures, laboratory instruction, and mentorship. Following his doctoral studies, he contributed to environmental chemistry as a laboratory manager, spearheading compliance-driven analytical methods, and later transitioned into the biotechnology sector as a research scientist, applying analytical and modeling techniques to sustainable material development. His current role as a postdoctoral fellow in neurology at the Icahn School of Medicine at Mount Sinai demonstrates his interdisciplinary adaptability, integrating chemistry with neuroscience to advance biomedical research.

Contributions and Research Focus

Dr. Sontising’s research has spanned computational chemistry, analytical method development, and biomedical applications. His doctoral work contributed to the understanding of crystal structures, intermolecular forces, and novel phases of elemental and molecular systems. In industry, he developed high-throughput analytical methods that accelerated workflows and improved efficiency in biomaterial research. At Mount Sinai, his focus has shifted toward metabolomics, lipidomics, and mass spectrometry imaging, where he is developing novel methods to study the chemical architecture of the brain. By combining advanced instrumentation with computational pipelines in R and Python, he has been able to elucidate metabolic pathways in neurological disease models, reinforcing the role of chemistry in unraveling complex biological processes.

Scholarly Publications

His contributions to the scientific community are reflected in a body of published work spanning computational chemistry, crystallography, photomechanical materials, polymerization mechanisms, and spatial metabolomics. His publications in journals such as Chemical Science, CrystEngComm, and Physical Review Materials highlight his ability to merge theoretical approaches with practical applications. Recent work in spatial metabolomics protocols has further expanded the methodological toolkit available to researchers studying brain metabolism, representing a bridge between chemical sciences and medical research.

Accolades and Recognition

Throughout his academic and professional career, Dr. Sontising has been recognized for his commitment to both research excellence and teaching impact. His role as a mentor, educator, and scientific contributor has been acknowledged through opportunities to supervise students, lead laboratory teams, and co-author impactful studies. His ability to secure and contribute to grant-funded projects demonstrates not only trust in his expertise but also recognition of his potential to shape innovative research directions.

Impact and Influence

The impact of his work can be seen in multiple spheres—students he has mentored, laboratories he has organized and modernized, and scientific knowledge he has advanced through publications and method development. By linking fundamental chemistry with applied biomedical research, Dr. Sontising has influenced how metabolomics and mass spectrometry are utilized in the study of neurological disorders. His interdisciplinary perspective allows for meaningful collaborations across chemistry, biology, and medicine, creating pathways for innovation that resonate beyond a single discipline.

Legacy and Future Contributions

Looking forward, Dr. Sontising is positioned to make lasting contributions at the intersection of chemistry and neuroscience. His ongoing development of novel imaging and analytical methods will continue to expand the understanding of brain chemistry and its relationship to disease. As an educator, he remains committed to shaping the next generation of scientists by integrating critical thinking, computational literacy, and practical laboratory expertise into the learning process. His legacy will likely be defined by both the scientific advancements he enables and the careers he helps foster, ensuring his influence endures in both the laboratory and the classroom.

Publications

  • Theoretical study on the mechanism and kinetics of ring-opening polymerization of cyclic esters initiated by tin(II) n-butoxide — C. Sattayanon, W. Sontising, J. Jitonnom, P. Meepowpan, W. Punyodom, … — 2014

  • Structural switching in self-assembled metal–ligand helicate complexes via ligand-centered reactions — L.R. Holloway, H.H. McGarraugh, M.C. Young, W. Sontising, G.J.O. Beran, … — 2016

  • Theoretical predictions suggest carbon dioxide phases III and VII are identical — W. Sontising, Y.N. Heit, J.L. McKinley, G.J.O. Beran — 2017

  • Effect of halogen substitution on energies and dynamics of reversible photomechanical crystals based on 9-anthracenecarboxylic acid — T.J. Gately, W. Sontising, C.J. Easley, I. Islam, R.O. Al-Kaysi, G.J.O. Beran, … — 2021

  • Theoretical study of the hydrogen abstraction of substituted phenols by nitrogen dioxide as a source of HONO — A. Shenghur, K.H. Weber, N.D. Nguyen, W. Sontising, F.M. Tao — 2014

  • Effects of alkoxide alteration on the ring-opening polymerization of ε-caprolactone initiated by n-Bu3SnOR: a DFT study — C. Sattayanon, W. Sontising, W. Limwanich, P. Meepowpan, W. Punyodom, … — 2015

  • Theoretical assessment of the structure and stability of the ε phase of nitrogen — W. Sontising, G.J.O. Beran — 2019

  • Combining crystal structure prediction and simulated spectroscopy in pursuit of the unknown nitrogen phase ε crystal structure — W. Sontising, G.J.O. Beran — 2020

  • Protocol for spatial metabolomics and isotope tracing in the mouse brain — W. Sontising, F. Yanchik-Slade, C. Rodriguez-Navas, M.A. Hossen, … — 2025

  • Combining Crystal Structure Prediction and Simulated Spectroscopy to Investigate Challenging High Pressure Phases — W. Sontising — 2020

Conclusion

Dr. Sontising’s career demonstrates a rare combination of scientific versatility, teaching excellence, and interdisciplinary innovation. His ability to move fluidly from theoretical chemistry to practical laboratory applications, and finally to biomedical research, underscores a dynamic approach that bridges multiple fields of science. He continues to shape the future of chemistry and neuroscience by developing novel analytical tools while inspiring the next generation of scientists through mentorship and education. His enduring influence lies in both his contributions to advancing knowledge and his commitment to empowering others, marking him as a researcher and educator of lasting impact.

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran,  Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

 

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients
    Author: PM Ridker
    Year: 2017

 

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
    Author: JL Witztum
    Year: 2019

 

  • Triglyceride lowering with pemafibrate to reduce cardiovascular risk
    Author: A Das Pradhan
    Year: 2022

 

  • Diabetes dyslipidemia
    Author: JD Schofield
    Year: 2016

 

  • Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
    Author: Ž Reiner
    Year: 2014

 

  • Obesity: a critical risk factor in the COVID‐19 pandemic
    Author: S Kwok
    Year: 2020

 

  • Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
    Author: KK Ray
    Year: 2019

 

  • Hypercholesterolaemia and its management
    Author: D Bhatnagar
    Year: 2008

 

  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
    Author: B Williams
    Year: 2018

 

  • Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
    Author: FJ Raal
    Year: 2017

 

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.